Human Longevity is a genomics and cell therapy-based diagnostic and therapeutic company. The company was founded in 2013 by Peter Diamandis, Robert Hariri, and Craig Venter. Human Longevity's mission is to extend the healthy human lifespan by developing and applying advanced technologies in genomics and cell therapy. The company's flagship product is the Health Nucleus, which is a comprehensive health assessment that uses whole genome sequencing and other advanced technologies to provide personalized health recommendations. Human Longevity has partnerships with various organizations, including Discovery Ltd., the Cleveland Clinic, and the University of California, San Diego.